DGPharma (0508.925.544): annual accounts, directors and company register

DGPharma

Ghent ·KBO/BCE: BE 0508.925.544

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

Company
DGPharma Ghent	€1.3m	€257,098	22.5%	0.2
MisYaprak België Brecht	€1.8m	€305,534	50.4%	0
VEYS E&S Oostrozebeke	€1.2m	€189,868	44.8%	0
ADRANO Yvoir	€0.8m	€234,530	69.2%	1.2
ZUSTO Mechelen	€1.1m	€69,443	71.6%	0.5
CAMUZEO Uccle	€0.7m	€70,115	25.6%	0.5
COLBARNIE Diksmuide	€2.0m	€59,714	35.9%	0

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Balance sheet: assets
`20/58`	1.3m	1.3m	1.4m	1.0m	704,622	633,945	432,256	393,290	325,526	216,383	180,820	203,985	121,402
`21/28`	41,038	25,526	23,329	21,296	6,805	2,000	4,000	6,000	8,000	-	-	-	-
`21`	41,038	25,526	23,329	21,296	6,805	2,000	4,000	6,000	8,000	-	-	-	-
`29/58`	1.3m	1.3m	1.4m	986,287	697,817	631,945	428,256	387,290	317,526	216,383	180,820	203,985	121,402
`3`	325,632	270,464	153,461	236,434	119,785	93,802	195,509	240,445	124,883	150,448	148,126	161,700	-
`30/36`	325,632	270,464	153,461	236,434	119,785	93,802	195,509	240,445	124,883	150,448	148,126	161,700	-
`40/41`	958,876	1.0m	1.2m	624,185	388,336	104,019	162,637	78,405	32,320	17,076	10,274	12,515	45,489
`40`	233,910	36,043	39,736	31,715	14,565	22,901	38,526	9,539	28,508	7,630	1,839	3,494	18,118
`41`	724,966	991,319	1.2m	592,470	373,770	81,118	124,111	68,866	3,813	9,446	8,435	9,020	27,372
`54/58`	-	-	0	118,242	185,062	432,179	68,489	68,403	160,207	48,596	22,308	29,661	75,805
`490/1`	8,364	21,040	15,248	7,425	4,635	1,946	1,621	37	116	263	112	110	107
Balance sheet: equity and liabilities
`10/49`	1.3m	1.3m	1.4m	1.0m	704,622	633,945	432,256	393,290	325,526	216,383	180,820	203,985	121,402
`10/15`	300,586	571,787	506,480	446,700	380,305	366,164	302,385	235,792	203,748	63,150	76,759	59,140	11,419
`10/11`	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	300,000	50,000	50,000	50,000	50,000
`100`	-	-	-	-	-	-	300,000	300,000	300,000	50,000	50,000	50,000	50,000
`13`	586	271,787	206,480	146,700	80,305	66,164	1,338	1,338	1,338	1,338	1,338	457	-
`130/1`	-	-	0	1,338	1,338	1,338	-	-	-	-	-	-	-
`130`	-	-	-	-	-	-	1,338	1,338	1,338	1,338	1,338	457	-
`1311`	-	-	0	1,338	1,338	1,338	-	-	-	-	-	-	-
`133`	586	271,787	206,480	145,362	78,967	64,826	-	-	-	-	-	-	-
`14`	0	-	-	0	0	0	1,047	-65,546	-97,590	11,812	25,421	8,683	-38,581
`17/49`	1.0m	772,606	906,659	560,883	324,317	267,781	129,871	157,498	121,778	153,233	104,061	144,846	109,982
`42/48`	1.0m	772,606	906,659	560,883	324,317	267,781	129,831	157,498	113,778	153,233	104,061	144,846	109,982
`43`	-	-	-	-	-	-	0	14	72	-	-	-	-
`430/8`	-	-	-	-	-	-	0	14	72	-	-	-	-
`44`	483,096	700,871	871,637	558,321	222,882	266,834	129,045	153,753	113,485	90,797	20,624	55,159	49,982
`440/4`	483,096	700,871	871,637	558,321	222,882	266,834	129,045	153,753	113,485	90,797	20,624	55,159	49,982
`45`	120,227	71,734	35,022	2,563	1,435	948	786	79	221	43	8,437	4,686	-
`450/3`	103,327	71,734	35,022	2,563	1,435	948	786	79	221	43	8,437	4,686	-
`454/9`	16,900	-	-	-	-	-	-	-	-	-	-	-	-
`47/48`	430,000	-	-	0	100,000	-	0	3,653	-	62,393	75,000	85,000	60,000
`492/3`	-	-	-	-	0	0	40	-	8,000	-	-	-	-
Income statement
`9900`	257,098	94,120	155,522	107,194	152,779	106,055	101,474	51,996	-64,026	20,583	44,011	62,836	-31,691
`62`	20,901	-	-	-	-	-	0	-242	27,898	19,578	-	-	-
`630`	11,373	6,702	5,364	4,198	2,002	2,000	2,000	2,000	2,000	-	-	-	-
`631/4`	-7,304	-11,519	18,887	-1,280	-22,192	9,733	13,740	-	-	-	-	-	-
`640/8`	2,522	3,132	39,863	2,265	34,447	713	10,329	453	451	562	450	449	353
`66A`	-	-	0	392	-	-	-	-	-	-	-	-	-
`9901`	229,606	95,805	91,408	101,619	138,523	93,609	75,406	49,785	-94,374	443	43,561	62,388	-32,044
`75/76B`	6,777	20,292	13,746	2,383	7,583	6,443	2,972	3,219	117	552	19	33	1
`75`	6,777	20,292	13,746	2,383	7,583	6,443	2,972	3,219	117	552	19	33	1
`65/66B`	14,070	13,615	12,903	14,198	26,764	19,897	11,785	20,960	15,067	14,560	17,520	10,008	6,538
`65`	14,070	13,615	12,903	14,198	26,764	19,897	11,785	20,960	15,067	14,560	17,520	10,008	6,538
`9903`	222,313	102,482	92,251	89,805	119,341	80,155	66,593	32,044	-109,323	-13,565	26,060	52,413	-38,580
`67/77`	63,514	37,175	32,471	23,409	5,200	16,376	-	-	79	43	8,441	4,693	0
`9904`	158,798	65,307	59,780	66,395	114,141	63,779	66,593	32,044	-109,402	-13,609	17,620	47,720	-38,581
`9905`	158,798	65,307	59,780	66,395	114,141	63,779	66,593	32,044	-109,402	-13,609	17,620	47,720	-38,581
Appropriation of the result
`9906`	158,798	65,307	59,780	66,395	114,141	64,826	1,047	-65,546	-97,590	11,812	26,302	9,140	-38,581
`791/2`	271,202	-	-	-	-	-	-	-	-	-	-	-	-
`691/2`	0	65,307	59,780	66,395	14,141	64,826	-	-	-	-	881	457	-
`6920`	-	-	-	-	-	-	-	-	-	-	881	457	-
`6921`	0	65,307	59,780	66,395	14,141	64,826	-	-	-	-	-	-	-
`694/7`	430,000	-	-	0	100,000	-	-	-	-	-	-	-	-
`694`	430,000	-	-	-	-	-	-	-	-	-	-	-	-
`695`	-	-	-	0	100,000	-	-	-	-	-	-	-	-
Social balance sheet
`9087`	0.2	-	0	0	-	-	-	-	0.4	0.7	-	-	-
Hours worked`1013`	88	-	-	-	-	-	-	-	813	1,117	-	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	30-06-2026	2026-00234717	PDF
31-12-2024	abbreviated format	22-07-2025	2025-00305561	PDF
31-12-2023	abbreviated format	05-07-2024	2024-00221950	PDF
31-12-2022	abbreviated format	31-08-2023	2023-00412942	PDF
31-12-2021	abbreviated format	16-06-2022	2022-20066869	PDF
31-12-2020	abbreviated format	29-06-2021	2021-26600486	PDF
31-12-2019	abbreviated format	04-08-2020	2020-39400476	PDF
31-12-2018	abbreviated format	30-08-2019	2019-61400344	PDF
31-12-2017	micro format	28-06-2018	2018-25000113	PDF
31-12-2016	micro format	14-06-2017	2017-17400049	PDF
31-12-2015	abbreviated format	17-06-2016	2016-19100544	PDF
31-12-2014	abbreviated format	08-07-2015	2015-28500175	PDF
31-12-2013	abbreviated format	26-06-2014	2014-23100022	PDF

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
240,978	102,507	96,772	105,817	140,524	95,609	77,406	51,785	-92,374	-	-	-	-
170,171	72,009	65,144	70,593	116,142	65,779	68,593	34,044	-107,402	-	-	-	-
26,884	8,900	7,396	18,690	6,806	0	0	0	10,000	-	-	-	-
-	-	-118,242	-66,820	-247,117	363,690	87	-91,804	111,611	26,288	-7,352	-46,144	-
259,548	546,261	483,151	425,404	373,500	364,164	298,425	229,792	203,748	63,150	76,759	59,140	11,419
22.5%	42.5%	35.8%	44.3%	54.0%	57.8%	70.0%	60.0%	62.6%	29.2%	42.5%	29.0%	9.4%
1.25	1.71	1.53	1.76	2.15	2.36	3.30	2.46	2.79	1.41	1.74	1.41	1.10
0.94	1.36	1.36	1.34	1.78	2.01	1.79	0.93	1.69	0.43	0.31	0.29	1.10
3.44	1.35	1.79	1.26	0.85	0.73	0.43	0.67	0.60	2.43	1.36	2.45	9.63
52.8%	11.4%	11.8%	14.9%	30.0%	17.4%	22.0%	13.6%	-53.7%	-21.5%	23.0%	80.7%	-337.8%
11.9%	4.9%	4.2%	6.6%	16.2%	10.1%	15.4%	8.1%	-33.6%	-6.3%	9.7%	23.4%	-31.8%
17.13	7.53	7.50	7.45	5.25	-	-	-	-	-	-	-	-

Item	31-12-2025
Employees at the balance-sheet date	1
full-time	0
part-time	1
in full-time equivalents	0.2
	0.2
On a permanent contract	1
Joined	1
Left	0
Training hours	3

Item	2025	2024	2023	2022	2021
Intangible fixed assets	€26,884	€8,900	€7,396	€18,690	€6,806
	€11,373	€6,702	€5,364	€4,198	€2,002

Ceres Pharma registered office since 28-10-2015 · founded in 2015 · negative equity (2025) · group Ceres Invest	37 FTE (2025) 0641.953.324
What’s Cooking Belgium registered office since 06-11-2006 · founded in 2006 · group What's Cooking Group	39 FTE (2025) 0884.649.304
What's Cooking Group registered office since 19-03-1981 · founded in 1981	48 FTE (2025) 0421.364.139
Ceres Invest registered office since 13-10-2021 · founded in 2021	turnover €2.5m (2025) 0775.683.264
Ceres Pharmaceuticals registered office since 27-05-2021 · founded in 1970 · group Ceres Invest	18 FTE (2025) 0407.326.754
Labophar registered office since 30-11-2015 · founded in 2015 · group Ceres Invest	turnover €406,703 (2025) 0643.723.177
CREDOPHAR registered office since 30-10-2012 · founded in 2012 · group Ceres Invest	total assets €7.8m (2025) 0849.730.193
MD Pharma registered office since 16-12-2016 · founded in 2016 · group Ceres Invest	total assets €2.7m (2025) 0667.779.672
b+pharma Belgium registered office since 02-08-2001 · founded in 2001 · group Ceres Invest	total assets €2.4m (2025) 0474.817.869
2PHARMA HOLDING registered office since 22-12-2015 · founded in 2015 · group Ceres Invest	total assets €1.9m (2025) 0644.751.377

Overview

Lifetime

Key points

Equity

Result

Debts

Investments

Filings

At the same address

Checked score

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Comparable companies

Official details

Annual accounts 2025

Companies linked to DGPharma

Parent and group

Insights on DGPharma

Financials

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cash

Position in the sector

Solvency22.5%

Current ratio1.25

Return on assets11.9%

Staff

Staff cost per FTE€104,507

Joined and left+1 person

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on DGPharma

Board & ownership

Board

Mandates through the years

Control

Capital

Owners through the years

Articles of association

Network & group

Group

Belgium 2 Equity Result

At the same address

Connections & network

Timeline

Timeline

History

Company details

Identity

Activities

Registered office and establishments

Buildings and parcels at the address

Location

Parcels

Recognitions

Food safety, FASFC

in euro

22.5%

1.25

11.9%

€104,507

+1 person